Abstract
Niridazole (Ambilhar) and three other newly synthesized nitrothiazole derivatives were highly active against 19 microaerophilic campylobacters (minimum concentration required to inhibit 50% of strains [MIC50], 0.0075 to 0.015 mg/liter). There were, however, considerable differences in the susceptibility among strains tested, and one nitrothiazole derivative was rather inactive (MIC50, 2 mg/liter). Nitroimidazole derivatives, such as metronidazole and tinidazole, were less active (MIC50, 2 and 4 mg/liter, respectively). The nitrofuran derivatives, such as nitrofurazone and nitrofurantoin, were also less active (MIC50, 1 mg/liter). Niridazole and another potent nitrothiazole derivative killed the campylobacters rapidly at low concentrations. In contrast, much higher concentrations of metronidazole were required to achieve bactericidal values.
Full text
PDF![498](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdf3/179952/32ecb05ad239/aac00187-0080.png)
![499](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdf3/179952/f5f7c493a3ea/aac00187-0081.png)
![500](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdf3/179952/017db4c4d68a/aac00187-0082.png)
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Freydière A. M., Gille Y., Tigaud S., Vincent P. In vitro susceptibilities of 40 Campylobacter fetus subsp. jejuni strains to niridazole and metronidazole. Antimicrob Agents Chemother. 1984 Jan;25(1):145–146. doi: 10.1128/aac.25.1.145. [DOI] [PMC free article] [PubMed] [Google Scholar]
- George H. A., Hoffman P. S., Smibert R. M., Krieg N. R. Improved media for growth and aerotolerance of Campylobacter fetus. J Clin Microbiol. 1978 Jul;8(1):36–41. doi: 10.1128/jcm.8.1.36-41.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hof H., Müller K. M. Antibakterielle Wirkung von Niridazol. II. Wirkung auf aerobe und anaerobe Bakterien. Zentralbl Bakteriol Mikrobiol Hyg A. 1982 Nov;253(2):265–271. [PubMed] [Google Scholar]
- Hof H., Sticht-Groh V. Antibacterial effects of niridazole: its effect on microaerophilic campylobacter. Infection. 1984 Jan-Feb;12(1):36–39. doi: 10.1007/BF01641023. [DOI] [PubMed] [Google Scholar]
- Hof H., Sticht-Groh V., Müller K. M. Comparative in vitro activities of niridazole and metronidazole against anaerobic and microaerophilic bacteria. Antimicrob Agents Chemother. 1982 Aug;22(2):332–333. doi: 10.1128/aac.22.2.332. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jordan P. Trial of ambilhar, a nitrothiazole derivative, in S. mansoni infections in Tanzania. Br Med J. 1966 Jan 29;1(5482):276–278. doi: 10.1136/bmj.1.5482.276. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Skirrow M. B. Campylobacter enteritis: a "new" disease. Br Med J. 1977 Jul 2;2(6078):9–11. doi: 10.1136/bmj.2.6078.9. [DOI] [PMC free article] [PubMed] [Google Scholar]